Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics
Jeroen van Bergenhenegouwen(Danone (Netherlands)), Anita Hartog(Nederlands Instituut Voor Zuivel Oonderzoek), Lieke Rutten(Nutricia Research (Netherlands)), Johan Garssen(Utrecht University), Aletta D. Kraneveld(Utrecht University), Arjan P. Vos(Danone (Netherlands))
Cited by 24
Related Papers
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation
|Nature Medicine|2006|495
Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice
|Gut|2018|489
Altered gut microbiota and activity in a murine model of autism spectrum disorders
|Brain Behavior and Immunity|2013|436
Exploring Braak’s Hypothesis of Parkinson’s Disease
|Frontiers in Neurology|2017|388
The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice
|Cellular and Molecular Life Sciences|2022|232